Technical Analysis for SLRX - Salarius Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Lower Bollinger Band Walk | Weakness | 5.81% | |
Stochastic Reached Oversold | Weakness | 5.81% | |
Inside Day | Range Contraction | 5.81% | |
Gapped Up | Strength | 5.81% | |
Lower Bollinger Band Touch | Weakness | 5.81% | |
Oversold Stochastic | Weakness | 5.81% | |
MACD Bearish Signal Line Cross | Bearish | 6.48% | |
BB Squeeze Ended | Range Expansion | 6.48% | |
Below Lower BB | Weakness | 6.48% | |
Down 3 Days in a Row | Weakness | 6.48% |
Alert | Time |
---|---|
Rose Above Previous Day's High | about 2 hours ago |
Rose Above 10 DMA | about 2 hours ago |
Up 5% | about 2 hours ago |
Up 3% | about 2 hours ago |
Up 2% | about 2 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Salarius Pharmaceuticals, Inc. a clinical-stage oncology company, develops therapies for the treatment of patients with various cancers. The company's lead candidate is Seclidemstat, which is in clinical development for the treatment of Ewing sarcoma, as well as advanced solid tumors, including prostate, breast, and ovarian cancers. Salarius Pharmaceuticals, Inc. is headquartered in Houston, Texas.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Solid Tumors Clinical Development Oncology Breast Cancer Prostate Cancer Ovarian Cancer Treatment Of Breast Cancer Sarcoma Advanced Solid Tumors
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Solid Tumors Clinical Development Oncology Breast Cancer Prostate Cancer Ovarian Cancer Treatment Of Breast Cancer Sarcoma Advanced Solid Tumors
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.8694 |
52 Week Low | 0.43 |
Average Volume | 134,462 |
200-Day Moving Average | 0.66 |
50-Day Moving Average | 0.53 |
20-Day Moving Average | 0.49 |
10-Day Moving Average | 0.49 |
Average True Range | 0.04 |
RSI (14) | 40.12 |
ADX | 24.85 |
+DI | 13.66 |
-DI | 12.45 |
Chandelier Exit (Long, 3 ATRs) | 0.43 |
Chandelier Exit (Short, 3 ATRs) | 0.58 |
Upper Bollinger Bands | 0.53 |
Lower Bollinger Band | 0.46 |
Percent B (%b) | 0.02 |
BandWidth | 15.48 |
MACD Line | -0.01 |
MACD Signal Line | -0.01 |
MACD Histogram | -0.002 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.50 | ||||
Resistance 3 (R3) | 0.50 | 0.49 | 0.49 | ||
Resistance 2 (R2) | 0.49 | 0.48 | 0.49 | 0.49 | |
Resistance 1 (R1) | 0.47 | 0.47 | 0.47 | 0.47 | 0.49 |
Pivot Point | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 |
Support 1 (S1) | 0.45 | 0.45 | 0.44 | 0.44 | 0.43 |
Support 2 (S2) | 0.44 | 0.45 | 0.43 | 0.43 | |
Support 3 (S3) | 0.42 | 0.44 | 0.42 | ||
Support 4 (S4) | 0.42 |